Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | AR-AG | $18,500,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MS-AG | $18,500,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,650,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | LA-AG | $20,000,000 |
ELANCO ANIMAL HEALTH A DIV OF ELI LILLY & CO CLINTON LABS | Elanco Animal Health | pharmaceuticals | air pollution violation | 2013 | IN-ENV | $20,000 |
ELANCO ANIMAL HEALTH A DIV OF ELI LILLY & CO CLINTON LABS | Elanco Animal Health | pharmaceuticals | air pollution violation | 2002 | IN-ENV | $17,000 |
Elan Pharmaceuticals Inc. | Perrigo | pharmaceuticals | export control violation | 2005 | BIS | $31,000 |
ELAN PHARMACEUTICALS INC. | Perrigo | pharmaceuticals | workplace safety or health violation | 2003 | OSHA | $7,125 |
ELAN PHARMACEUTICALS INC. | Perrigo | pharmaceuticals | workplace safety or health violation | 2004 | OSHA | $18,225 |
Elan Corporation, plc | Perrigo | pharmaceuticals | accounting fraud or deficiencies | 2005 | SEC | $15,000,000 |
Elan Corporation PLC | Perrigo | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $203,000,000 |
Eisai Inc. | Eisai | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $11,000,000 |
EISAI INC. | Eisai | pharmaceuticals | workplace safety or health violation | 2010 | OSHA | $6,376 |
Eisai Company | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Eisai Co. | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $2,544,900 |
Eisai Co. | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Eisai | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $7,634,700 |
Eisai | Eisai | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,000,000 |
E.R. Squibb & Sons LLC | Bristol-Myers Squibb | pharmaceuticals | PCB violation | 2009 | EPA | $8,125 |
E.R. SQUIBB & SONS | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2009 | NJ-ENV | $10,000 |
E. Merck KG | Merck KGaA (EMD) | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | private lawsuit-federal | $50,000,000 |
E R SQUIBB & SONS LLC | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2013 | NJ-ENV | $5,950 |
DUSA Pharmaceuticals, Inc. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $20,750,000 |
DURAMED PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2001 | OSHA | $7,000 |
DuPont Pharmaceuticals Company | Bristol-Myers Squibb | pharmaceuticals | economic sanction violation | 2004 | OFAC | $6,600 |
Dr. Reddy's Laboratories Ltd. | Dr. Reddy's Laboratories | pharmaceuticals | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $400,000 |
Dr. Reddy's Laboratories Inc. | Dr. Reddy's Laboratories | pharmaceuticals | drug or medical equipment safety violation | 2018 | DOJ_CIVIL | $5,000,000 |
Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | pharmaceuticals | False Claims Act and related | 2022 | TX-AG | $12,900,000 |
Dey, Inc. | Viatris | pharmaceuticals | fraud | 2004 | AR-AG | $600,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2007 | HI-AG | $1,150,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2006 | ID-AG | $1,072,700 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | KY-AG | $3,500,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2007 | MA-AG | $2,900,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2007 | NV-AG | $670,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | WI-AG | $2,000,000 |
Dey, Inc. | Viatris | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Dey Pharmaceuticals | Viatris | pharmaceuticals | False Claims Act and related | 2011 | PA-AG | $2,000,000 |
Dey LP | Viatris | pharmaceuticals | False Claims Act and related | 2007 | MT-AG | $198,000 |
Dey Labs | Viatris | pharmaceuticals | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
Dey L.P. | Viatris | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $4,750,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2005 | CT-AG | $2,500,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2006 | MO-AG | $2,932,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2006 | OH-AG | $4,000,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2004 | WV-AG | $850,000 |
Dey | Viatris | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
Depuy Synthes Sales, Inc. | Johnson & Johnson | pharmaceuticals | wage and hour violation | 2020 | CA-LCO | $57,488 |
DEPUY SYNTHES PRODUCTS, LLC | Johnson & Johnson | pharmaceuticals | workplace safety or health violation | 2018 | OSHA | $5,654 |
DEPUY SYNTHES PRODUCTS, INC. | Johnson & Johnson | pharmaceuticals | workplace safety or health violation | 2022 | OSHA | $7,044 |
DEPUY SYNTHES | Johnson & Johnson | pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $5,000 |
DePuy Synthes | Johnson & Johnson | pharmaceuticals | hazardous waste violation | 2019 | EPA | $51,750 |
DePuy Orthopaedics Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2014 | OR-AG | $4,000,000 |
Dava Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000 |
Dava Pharmaceuticals Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2012 | DOJ_CIVIL | $11,000,000 |
Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $4,340,100 |
Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $1,446,700 |
Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Cytrx Corporation | CytRx | pharmaceuticals | investor protection violation | 2017 | SEC | $75,000 |
Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |
CSL Plasma Inc. | CSL Limited | pharmaceuticals | privacy violation | 2022 | private lawsuit-federal | $9,900,000 |
CSL PLASMA | CSL Limited | pharmaceuticals | workplace safety or health violation | 2019 | OSHA | $15,422 |
CSL Limited | CSL Limited | pharmaceuticals | price-fixing or anti-competitive practices | 2014 | private lawsuit-federal | $64,000,000 |
CSL Behring, LLC | CSL Limited | pharmaceuticals | air pollution violation | 2021 | EPA | $527,144 |
CSL Behring LLC | CSL Limited | pharmaceuticals | air pollution violation | 2015 | EPA | $62,780 |
CSL BEHRING LLC | CSL Limited | pharmaceuticals | air pollution violation | 2021 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $527,144 |
COVIDIEN DBA MALLINCKRODT INC. | Mallinckrodt | pharmaceuticals | workplace safety or health violation | 2010 | OSHA | $41,613 |
Cody Laboratories Inc | Lannett Co. | pharmaceuticals | motor vehicle safety violation | 2018 | FMCSA | $8,510 |
Clovis Oncology Inc. | Clovis Oncology | pharmaceuticals | investor protection violation | 2018 | SEC | $20,000,000 |
CIBA Vision | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $5,000,000 |
Chiron Corporation Ltd | Novartis | pharmaceuticals | economic sanction violation | 2004 | OFAC | $168,500 |
CHIRON CORPORATION | Novartis | pharmaceuticals | workplace safety or health violation | 2000 | OSHA | $90,140 |
CHEROKEE PHARMACEUTICALS LLC | Merck | pharmaceuticals | benefit plan administrator violation | 2011 | EBSA | $10,001 |
Cherokee Pharmaceuticals | Merck | pharmaceuticals | railroad safety violation | 2021 | FRA | $5,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | CT-AG | $6,150,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,500,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $7,500,000 |
Cephalon | Teva Pharmaceutical Industries | pharmaceuticals | consumer protection violation | 2016 | MULTI-AG | $125,000,000 |
Celgene Corporation | Bristol-Myers Squibb | pharmaceuticals | PCB violation | 2013 | EPA | $6,035 |
Celgene Corp. | Bristol-Myers Squibb | pharmaceuticals | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000 |
CAMBRIDGE MAJOR LABORATORIES INC | Alcami | pharmaceuticals | motor vehicle safety violation | 2006 | FMCSA | $18,560 |
CAMBRIDGE MAJOR LABORATORIES INC | Alcami | pharmaceuticals | motor vehicle safety violation | 2005 | FMCSA | $15,820 |
CAMBREX CHARLES CITY, INC. | Cambrex | pharmaceuticals | workplace safety or health violation | 2007 | OSHA | $6,375 |
CAMBREX CHARLES CITY, INC. | Cambrex | pharmaceuticals | workplace safety or health violation | 2018 | OSHA | $18,000 |
CAMBREX CHARLES CITY, INC | Cambrex | pharmaceuticals | hazardous waste violation | 2006 | EPA | $106,749 |
Bristol-Myers Squibb Medical Imaging, Inc. | Bristol-Myers Squibb | pharmaceuticals | export control violation | 2004 | BIS | $16,200 |
Bristol-Myers Squibb Company and Apothecon, Inc. | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | accounting fraud or deficiencies | 2004 | SEC | $150,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2011 | CT-ENV | $20,000 |
BRISTOL-MYERS SQUIBB COMPANY | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2000 | EPA | $5,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $10,000,000 |
Bristol-Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $19,000,000 |
BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2003 | NJ-ENV | $28,000 |
BRISTOL-MYERS SQUIBB CO | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2001 | NJ-ENV | $6,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | drug or medical equipment safety violation | 2007 | DOJ_ANTITRUST | $1,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | air pollution violation | 2008 | EPA | $3,650,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | fraud | 2005 | USAO | $300,000,000 |